Market Access: MedTech

Value-Based Access Programs

Communicating value to the market

Alira Health has the industry and market experience to communicate the value of your healthcare device or life science innovation. We specialize in helping early stage developers and late stage innovators communicate the hidden value of their products, increasing market access.

Solutions designed for commercial success

Our Center for Healthcare Economics and Outcomes Research (HEOR) team provides a range of solutions to communicate your value to the market and ensure commercial success. Our team works closely with clients to:
  • Identify key solutions that when implemented would satisfy a clear unmet need
  • Align internal messaging around the MAP™ diagnostic
  • Engage external stakeholders and develop a project charter
  • Identify local sites and clinical engagement
  • Monitor and track identified outcomes
  • Determine viability of program
  • Develop outcomes report
  • Scale up where possible

Why choose Alira Health?

Our fully integrated market access team understands the nuances of launching in today’s market. As your partner, we’ll provide:

  • Access to a diverse, integrated team with deep industry expertise
  • Close collaboration with our regulatory and clinical practices to support a holistic commercialization strategy
  • Specific, local insights as part of your larger, global strategy—a benefit of having market access teams in both the EU and U.S.

Working together to transform healthcare

Whether you need to understand which asset best aligns with your long-term strategy, which new market or therapeutic area to explore, or how to expand into another sector, we are ready to help you lead the way.

Contact us
Richard Charter
Richard Charter
Vice President, Market Access, MedTech, Europe and Asia-Pacific
Our holistic, lifecycle approach to market access provides clients with maximum clinical and economic value for their technology while supporting patient-centered, value-based healthcare.

Related News

Market Access MedTech
Multimedia February 26, 2021
Pricing in MedTech: Disentangling the Roles of Payers, DRGs, and Procurement
Join host Kenny Carberry, Associate Director of Clinical Development, Dan Legg, former Director of Clinical Sourcing at Guy’s & St Thomas at the St Thomas Hospital in London and CEO(...)
MedTech Pharma
Publications February 8, 2021
Infographic: 2021 Trends in Healthcare
It is no secret that the COVID-19 pandemic has presented new challenges for businesses, and virtual has become the ‘new normal’, including for transactions.
MedTech Pharma
News February 4, 2021
2020 Year in Review
With 2021 in full swing, we want to take a moment to reflect on last year’s achievements and congratulate the entire Alira Health Team for their hard work and dedication to healthcare(...)
Market Access MedTech
Publications December 5, 2020
Critical Success Factors in Market Access
Today’s MedTech market is more concentrated than ever, with critical factors that need to be examined to advance a new product.
Market Access Pharma
Publications November 2, 2020
WHO Guideline: Summary of Recommendations on Pharmaceutical Pricing Policies
The WHO recently launched a series of recommendations on pharmaceutical pricing policies to help countries make medicines more affordable for the global population and lessen the burden(...)
Advanced Analytics Market Access Pharma
Publications November 1, 2020
Our Parallel Trade Expertise
Alira Health is proud to announce our new collaboration with Mark Inigo Jones, an industry leader in European parallel trade of pharmaceutical products.
M&A MedTech
Publications October 10, 2020
Q3 2020 Medical Device Contract Development and Manufacturing M&A Report
Despite the COVID-19 pandemic, M&A activity in the global CDMO industry has been exceptionally strong in 2020 with a record number of transactions completed during the third quarter alone.

Our locations around the globe

Welcome to Alira Health. This site is best viewed in Chrome, Microsoft Edge, or Firefox.